title: Osteoarthritis year in review 2015: clinical.
abstract: The purpose of this review is to highlight clinical research in osteoarthritis (OA). A literature search was conducted using PubMed (http://www.ncbi.nlm.nih.gov/pubmed/) with the search terms "osteoarthritis [All Fields] AND treatment [All Fields]" and the following limits activated: humans, English language, all adult 19+ years, published between April 1, 2014 and April 1, 2015. A second literature search was then conducted with the search terms "osteoarthritis [All Fields] AND epidemiology [All Fields]", with the same limits. Reports of surgical outcome, case series, surgical technique, tissue sample or culture studies, trial protocols, and pilot studies were excluded. Of 1523, 150 were considered relevant. Among epidemiologic and observational clinical studies, themes included physical activity, early knee OA, and confidence/instability/falls. Symptom outcomes of pharmacologic treatments were reported for methotrexate, adalimumab, anti-nerve growth factor monoclonal antibodies, strontium ranelate, bisphosphonates, glucosamine, and chondroitin sulfate, and structural outcomes of pharmacologic treatments for strontium ranelate, recombinant human fibroblast growth factor 18, and glucosamine and chondroitin sulfate. Symptom outcomes of non-pharmacologic interventions were reported for: neuromuscular exercise, quadriceps strengthening, weight reduction and maintenance, TENS, therapeutic ultrasound, stepped care strategies, cognitive behavior therapy for sleep disturbance, acupuncture, gait modification, booster physical therapy, a web-based therapeutic exercise resource center for knee OA; hip physical therapy for hip OA; and joint protection and hand exercises for hand OA. Structure outcomes of non-pharmacologic interventions were reported for patellofemoral bracing.
authors.affiliation: Northwestern University, Chicago IL, United States. Electronic address: L-Sharma@northwestern.edu.
authors.forename: L
authors.initials: L
authors.lastname: Sharma
mesh_terms: D000068879:Adalimumab / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D019643:Arthroplasty, Replacement; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D002809:Chondroitin Sulfates / Q000627:therapeutic use; D015928:Cognitive Behavioral Therapy; D004164:Diphosphonates / Q000627:therapeutic use; D005081:Exercise Therapy; D005944:Glucosamine / Q000627:therapeutic use; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use; D010003:Osteoarthritis / Q000628:therapy*; D026741:Physical Therapy Modalities; D055070:Resistance Training; D013876:Thiophenes / Q000627:therapeutic use; D004561:Transcutaneous Electric Nerve Stimulation; D016896:Treatment Outcome; D014464:Ultrasonic Therapy
chemical_list: D018501:Antirheumatic Agents; D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D013876:Thiophenes; C081587:strontium ranelate; D002809:Chondroitin Sulfates; D000068879:Adalimumab; D005944:Glucosamine; D008727:Methotrexate
keywords: Epidemiology; Function; Imaging; Osteoarthritis; Pain; Treatment